Please login to the form below

Not currently logged in
Email:
Password:

stem cells

This page shows the latest stem cells news and features for those working in and with pharma, biotech and healthcare.

Mesoblast’s stem cell therapy fails to meet primary endpoint in COVID-19 study

Mesoblast’s stem cell therapy fails to meet primary endpoint in COVID-19 study

Australian biotech company Mesoblast announced on Friday that its stem cell therapy remestemcel-L failed to meet the primary endpoint in a phase 3 COVID-19 trial. ... Remestemcel-L is comprised of culture-expanded mesenchymal stem cells taken from the

Latest news

More from news
Approximately 5 fully matching, plus 114 partially matching documents found.

Latest Intelligence

  • AI and genomics: a revolution in drug discovery and development AI and genomics: a revolution in drug discovery and development

    The next step of the process was to work with a partner to run the most promising targets through various confirmatory assays, including phenotypic assessments using stem cells from patients.

  • Delivering the promise of regenerative medicine Delivering the promise of regenerative medicine

    Replenish. Replace. Rejuvenate. Stem cells can generate vital growth factors to naturally reduce inflammation, increase muscle mass, repair joints, grow hair and boost the immune system, replenishing the body. ... The root causes of ageing are being

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    CTX001 is an ex vivo therapy, meaning. the CRISPR technology is used to modify haematopoietic stem cells outside the body to express foetal haemoglobin, and then reinfused into the patient. ... hope was that - without the brake of PD-1 – the edited

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    Kathy Niakan is a group leader at London's academic research hub The Francis Crick Institute.and is investigating the mechanisms of lineage specification in human embryos and stem cells. ... of infertility, miscarriages and developmental disorders, and

  • Deal Watch January 2018

    Takeda moves in neurodegenerative diseases and stem cell therapy. Meanwhile Takeda, ranked 4. ... Option exercise (2 options). 640. TiGenix/Takeda. Cx601, lead asset, allogeneic expanded adipose-derived stem cells (eASC) locally administered for

More from intelligence
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics